HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.

Qian L, Ji AH, Zhang WJ, Zhao N

Open source

DOI
10.26355/eurrev_201801_14192
Published
2018 Jan
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201801_14192,
  title = {HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.},
  author = {Qian L and Ji AH and Zhang WJ and Zhao N},
  year = {2018},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201801_14192},
  url = {https://doi.org/10.26355/eurrev_201801_14192}
}

RIS

TY  - JOUR
TI  - HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.
AU  - Qian L
AU  - Ji AH
AU  - Zhang WJ
AU  - Zhao N
PY  - 2018
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201801_14192
UR  - https://doi.org/10.26355/eurrev_201801_14192
ER  - 

APA

L, Q., AH, J., WJ, Z., & N, Z. (2018). HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201801_14192

Source records